Trial intelligence / Profile preview

Intranasal dexmedetomidine sedation for echocardiography in children

ChiCTR-ONC-14004250Phase 4Completed

Sponsor
Guangzhou Women and Children's Medical Centre
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of dexmedetomidine in Cardiovascular Malformation (CVM), sponsored by Guangzhou Women and Children's Medical Centre. Primary endpoints: Onset time, Wake up time and 1 more. Started May 2012; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on ChiCTR-ONC-14004250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONC-14004250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call